These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10089786)

  • 1. Incidence of inflammatory bowel disease in the 02 health area of Castellon (1992-1996).
    Monferrer Guardiola R; Martín Jiménez JA; Pedraza Sanz RG; Moreno Sánchez I; Soler Bahilo E; Hinojosa del Val J
    Rev Esp Enferm Dig; 1999 Jan; 91(1):33-46. PubMed ID: 10089786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of inflammatory bowel disease in the 02 health area of Castellón (1992-1996).
    Monferrer Guardiola R ; Marín Jiménez JA ; Pedraza Sanz RG ; Moreno Sánchez I ; Soler Bahilo E ; Hinojosa del Val J
    Rev Esp Enferm Dig; 1999 Jan; 91(1):40-46. PubMed ID: 10217801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incidence and prevalence of inflammatory bowel disease in Gijon, Asturias, Spain].
    Saro Gismera C; Lacort Fernández M; Argüelles Fernández G; Antón Magarzo J; García López R; Navascues CA; Suárez González A; Díaz Alvarez G; González Bernal A; Palacios Galán A; Altadill Arregui A; Vizoso F
    Gastroenterol Hepatol; 2000; 23(7):322-7. PubMed ID: 11002532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
    Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF
    Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].
    Flamenbaum M; Zénut M; Aublet-Cuvelier B; Larpent JL; Fabre P; Abergel A; Dapoigny M; Bommelaer G
    Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inflammatoru bowel disease in Aragón: a more and more frequent diagnosis].
    Cella Lanau J; López Zaborras J; Gomollón García F; Sáinz Samitier R
    Rev Esp Enferm Dig; 1995 May; 87(5):363-7. PubMed ID: 7626295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological aspects of inflammatory bowel disease in the Pamplona area.
    Arin Letamendia A; Burusco Paternain MJ; Borda Celaya F; Pueyo Royo A; Martínez Echeverría A; Jiménez Pérez FJ
    Rev Esp Enferm Dig; 1999 Nov; 91(11):769-76. PubMed ID: 10601770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence of inflammatory bowel disease in Sagunto].
    Hinojosa J; Primo J; Lledó S; López A; Roig JV; Fernández J
    Rev Esp Enferm Dig; 1990 Nov; 78(5):283-7. PubMed ID: 2090171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology in inflammatory bowel disease in five areas of Asturias. Spain].
    Saro Gismera C; Riestra Menéndez S; Sánchez Fernández R; Milla Crespo A; Lacort Fernández M; Argüelles Fernández G; Chobak Z; Florido Mancheño JI; Antón Magarzo JL; Altadill Arregui A; Vizoso F; Pineda García E; Fernández de Ocariz Archs E; Albert Colomer J; García Pérez J; López Rivas L; Lombraña JL
    An Med Interna; 2003 May; 20(5):232-8. PubMed ID: 12831296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence and prevalence of inflammatory bowel disease. Asturian study in 5 areas (EIICEA). Spain].
    Saro Gismera C; Riestra Menéndez S; Milla Crespo A; Sánchez Fernández R; Lacort Fernández M; Argüelles Fernández G; Chovac Z; Florido Mancheño JI; Antón Magarzo JL; Altadill Arregui A; Vizoso F; Pineda García E; Fernández de Ocariz Archs E; Albert Colomer J; García Pérez J; López Rivas L; Lombraña JL
    An Med Interna; 2003 Jan; 20(1):3-9. PubMed ID: 12666301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence of inflammatory bowel disease in Aragon: outcome of a prospective population-based study].
    Lopez Miguel C; Sicilia B; Sierra E; Lopez Zaborras J; Arribas F; Gomollon F
    Gastroenterol Hepatol; 1999; 22(7):323-8. PubMed ID: 10535203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
    Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of inflammatory bowel disease in the pediatric population of Southwestern Ontario.
    Grieci T; Bütter A
    J Pediatr Surg; 2009 May; 44(5):977-80. PubMed ID: 19433182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological aspects of inflammatory bowel disease in a north Italian population: a 4-year prospective study.
    Ranzi T; Bodini P; Zambelli A; Politi P; Lupinacci G; Campanini MC; Dal Lago AL; Lisciandrano D; Bianchi PA
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):657-61. PubMed ID: 8853254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
    Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P;
    Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic inflammatory bowel disease in children. An epidemiological study from eastern Denmark 1998-2000].
    Urne FU; Paerregaard A
    Ugeskr Laeger; 2002 Dec; 164(49):5810-4. PubMed ID: 12523226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Wajda A; Blanchard JF
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.